Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations.
Ceren ŞerefOmer AcarMert KilicMetin VuralYesim SaglicanHilal SaraçBilgen CoşkunÜmit İnceTarık EsenNathan A LackPublished in: The Prostate (2021)
Histologically benign PI-RADS 4 and 5 lesions harbor prostate cancer-associated epigenetic alterations.